Disclosure: We earn commissions on purchases made through our links. This never influences our scores. Editorial policy
Policosanol
Policosanol is the cleanest example of a supplement where the entire evidence base comes from one research group, and no independent lab can reproduce it.
- Evidence
- Weak Evidence
- Category
- Heart & Cardiovascular
- Best form
- Cuban sugar cane wax policosanol (the original trial material from Dalmer Laboratories, not commercially sold in the US)
- Effective dose
- 5-20mg daily of a sugar cane policosanol blend (this is the dose used in both the original Cuban trials and the negative independent replication trials)
- Lab tested
- 1 of 10 products
- Category
- Heart & Cardiovascular
- Best form
- Cuban sugar cane wax policosanol (the original trial material from Dalmer Laboratories, not commercially sold in the US)
- Effective dose
- 5-20mg daily of a sugar cane policosanol blend (this is the dose used in both the original Cuban trials and the negative independent replication trials)
- Lab tested
- 1 of 10 products
Key takeaways
- →The cholesterol claim has failed every independent replication: Berthold 2006 JAMA, Greyling 2006, Cubeddu 2006 all found zero LDL effect.
- →Cuban trials from one research group reported 18-30% LDL reductions, never reproduced outside Havana despite 80+ original positive papers.
- →If you want a non-statin LDL option, red yeast rice, bergamot, berberine, and plant sterols all have stronger independent evidence.
- →Safe and cheap (~$0.10-0.40/day), so a 12-week personal trial at 20mg with before/after lipid panels is reasonable if you accept it likely won't work.
What Is Policosanol?
Policosanol is the cleanest example of a supplement where the entire evidence base comes from one research group, and no independent lab can reproduce it. Skip this for cholesterol. The Cuban research group at the Center of Natural Products in Havana published more than 80 trials between the early 1990s and mid-2000s reporting LDL reductions of 18 to 30 percent at doses of 5 to 20mg per day, numbers that approach low-dose statin territory. Once outside investigators picked up the same molecule and ran their own placebo-controlled trials, the effect vanished.
The pivotal independent trial is Berthold et al. 2006 in JAMA: 143 patients with hypercholesterolemia, four policosanol doses (10, 20, 40, 80mg/day) plus placebo, 12 weeks. None of the policosanol arms reduced LDL by more than 10 percent, and no dose beat placebo on any lipid endpoint. Greyling et al. 2006 (British Journal of Nutrition) ran a crossover trial of 20mg/day for 12 weeks in hypercholesterolemic and familial hypercholesterolemic patients and saw no significant lipid effect. Cubeddu et al. 2006 (American Heart Journal) directly compared 20mg policosanol against 10mg atorvastatin: atorvastatin cut LDL 35 percent, policosanol did nothing, and adding policosanol to atorvastatin gave no additional benefit. Dulin et al. 2006 (American Journal of Clinical Nutrition) and Kassis & Jones 2006 found the same null result with Cuban-source material.
The mechanistic story is that octacosanol and the other long-chain alcohols in the mix supposedly down-regulate HMG-CoA reductase activity and increase LDL receptor expression, the same pathway statins target. In theory it should work. In independently run trials it does not. The most likely explanation is that the original Cuban trials had methodological issues that did not survive blinded, externally adjudicated replication, possibly the unblinded conduct, the patient selection, or the lipid assay protocol. The molecule itself is real and the mechanism is plausible, but the clinical effect on LDL in standard hypercholesterolemic patients has not been reproduced outside Havana.
Platelet aggregation is the one area with weak independent signal. Cuban work showed dose-dependent inhibition of ADP-induced platelet aggregation, and at least one non-Cuban trial replicated a partial effect, though the clinical relevance is unclear and dose response is inconsistent. There is zero hard cardiovascular outcome data: no MACE trials, no mortality data, no atherosclerosis progression imaging. If you want a non-statin LDL-lowering option, the evidence supports red yeast rice (with monacolin K standardization), bergamot, plant sterols, and berberine well ahead of policosanol. If you want to try policosanol anyway, do a 12-week trial at 20mg/day with a baseline and follow-up lipid panel and accept that the most likely outcome is no change.
Does It Work? The Evidence
How A-F grades workLDL cholesterol reduction
Berthold 2006 JAMA (n=143, no effect at 10-80mg); Greyling 2006 Br J Nutr (no effect at 20mg/12wk); Cubeddu 2006 Am Heart J (no effect vs atorvastatin); Dulin 2006 AJCN (no effect at 20mg/8wk); Kassis & Jones 2006 AJCN (no effect with Cuban-source material). Cuban trials by Mas, Castano, Batista report 18-30% reductions but have never been independently replicated.
HDL cholesterol increase
Cuban trials report 7-29% HDL increases; Berthold 2006 and Cubeddu 2006 found no significant HDL change vs placebo. Same replication-failure pattern as LDL.
Triglyceride reduction
Cuban trials show modest reductions; independent trials (Berthold 2006, Greyling 2006, Dulin 2006) show no effect.
Platelet aggregation inhibition
Valdes 1996 and Arruzazabala 2002 showed dose-dependent inhibition of ADP-induced platelet aggregation at 10-20mg/day; partial replication exists but clinical relevance is unclear and no thrombosis-outcome data.
Cardiovascular outcomes (heart attack, stroke, mortality)
No randomized trials with hard cardiovascular endpoints. No MACE data. No atherosclerosis-progression imaging trials. All claims here are extrapolated from surrogate lipid markers that themselves do not reproduce.
| Grade | Claimed Benefit | Key Studies | Our Verdict |
|---|---|---|---|
| D | LDL cholesterol reduction | Berthold 2006 JAMA (n=143, no effect at 10-80mg); Greyling 2006 Br J Nutr (no effect at 20mg/12wk); Cubeddu 2006 Am Heart J (no effect vs atorvastatin); Dulin 2006 AJCN (no effect at 20mg/8wk); Kassis & Jones 2006 AJCN (no effect with Cuban-source material). Cuban trials by Mas, Castano, Batista report 18-30% reductions but have never been independently replicated. | Conflicted |
| D | HDL cholesterol increase | Cuban trials report 7-29% HDL increases; Berthold 2006 and Cubeddu 2006 found no significant HDL change vs placebo. Same replication-failure pattern as LDL. | Conflicted |
| D | Triglyceride reduction | Cuban trials show modest reductions; independent trials (Berthold 2006, Greyling 2006, Dulin 2006) show no effect. | Conflicted |
| C | Platelet aggregation inhibition | Valdes 1996 and Arruzazabala 2002 showed dose-dependent inhibition of ADP-induced platelet aggregation at 10-20mg/day; partial replication exists but clinical relevance is unclear and no thrombosis-outcome data. | Early Signal |
| F | Cardiovascular outcomes (heart attack, stroke, mortality) | No randomized trials with hard cardiovascular endpoints. No MACE data. No atherosclerosis-progression imaging trials. All claims here are extrapolated from surrogate lipid markers that themselves do not reproduce. | Not There Yet |
How to Choose: Forms, Doses & What Matters
Clinical dose: 5-20mg daily of a sugar cane policosanol blend (this is the dose used in both the original Cuban trials and the negative independent replication trials)
Best forms: Cuban sugar cane wax policosanol (the original trial material from Dalmer Laboratories, not commercially sold in the US), Sugar cane wax-derived policosanol (most US retail products, ~60% octacosanol), Beeswax-derived policosanol (different alcohol profile, even less evidence), Rice bran wax-derived policosanol (Jarrow Ultra Policosanols uses this; different alcohol mix)
If you choose to try it: 10-20mg once daily, ideally in the evening (the original Cuban protocols dosed at dinner, theorizing it would align with peak overnight cholesterol synthesis). Take with or without food. Allow at least 8-12 weeks before drawing any conclusion, and book a baseline lipid panel before starting plus a repeat panel at 12 weeks. If your LDL has not moved meaningfully, stop. Do not stack with prescription statins or anticoagulants without physician supervision.
Who Should Take Policosanol?
Honestly, very few people. The evidence does not support policosanol as a reliable cholesterol intervention. If you specifically want to try a non-statin, non-prescription cholesterol supplement and have already considered red yeast rice (better evidence), bergamot, plant sterols, or berberine, a 12-week trial at 20mg/day with baseline and follow-up lipid panels is low-risk and low-cost. People interested in the platelet aggregation effect could consider it, but aspirin is far better studied for that purpose. Do not use policosanol as a statin replacement or as a primary intervention for established hyperlipidemia or known cardiovascular disease.
Who Should Avoid It?
Not for everyone
Side Effects & Safety
Product Scores
10 products scored on dosing accuracy, third-party testing, cost per effective dose, and label transparency.
The Scorecard: 10 Products Compared
Policosanol 20mg
Pure Encapsulations$49.20 ÷ 120 days at 20mg/day (1 serving × 20mg)
Best execution in the category, but the underlying clinical question is whether the molecule does anything at all in independent trials.
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Policosanol 20mg
Solgar$29.99 ÷ 100 days at 20mg/day (1 serving × 20mg)
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Policosanol 20mg Double Strength
NOW Foods$18.99 ÷ 90 days at 20mg/day (1 serving × 20mg)
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Policosanol 10mg
NOW Foods$14.49 ÷ 91 days at 10mg/day (1 serving × 10mg)
Reasonable execution on a supplement whose core efficacy claim does not hold up outside the original Cuban research group.
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Policosanol 20mg
Swanson
$11.99 ÷ 60 days at 20mg/day (1 serving × 20mg)
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Policosanol 20mg
Source Naturals
$16.30 ÷ 60 days at 20mg/day (1 serving × 20mg)
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Ultra Policosanols 10mg
Jarrow Formulas$23.99 ÷ 100 days at 10mg/day (1 serving × 10mg)
If you want to try non-sugar-cane policosanol, this is one of the few transparent rice-derived options, but the absorption claim does not solve the underlying replication problem.
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Policosanol 23mg
Nature's Life
$14.99 ÷ 60 days at 23mg/day (1 serving × 23mg)
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Policosanol 10mg
Best Naturals
$15.99 ÷ 123 days at 10mg/day (1 serving × 10mg)
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Policosanol 40mg
Horbaach$19.99 ÷ 200 days at 40mg/day (1 serving × 40mg)
If you are determined to try policosanol cheaply, this is the cheapest reputable option, but a higher dose does not fix the underlying replication problem.
Prices checked 2026-04-26. Cost shown is per clinically effective daily dose, not per pill.
Full Comparison
| Category | Policosanol 20mg Pure Encapsulations | Policosanol 20mg Solgar | Policosanol 20mg Double Strength NOW Foods | Policosanol 10mg NOW Foods | Policosanol 20mg Swanson | Policosanol 20mg Source Naturals | Ultra Policosanols 10mg Jarrow Formulas | Policosanol 23mg Nature's Life | Policosanol 10mg Best Naturals | Policosanol 40mg Horbaach |
|---|---|---|---|---|---|---|---|---|---|---|
| Brand Score | 81/100Winner | 80/100 | 79/100 | 78/100 | 76/100 | 75/100 | 73/100 | 70/100 | 68/100 | 64/100 |
| Dosing & Form | 22/25Winner | 22/25 | 22/25 | 19/25 | 22/25 | 22/25 | 17/25 | 22/25 | 19/25 | 16/25 |
| Purity | 22/25Winner | 19/25 | 19/25 | 19/25 | 16/25 | 16/25 | 17/25 | 13/25 | 13/25 | 13/25 |
| Value | 14/25 | 17/25 | 21/25 | 23/25Winner | 21/25 | 20/25 | 18/25 | 18/25 | 22/25 | 22/25 |
| Transparency | 23/25Winner | 22/25 | 17/25 | 17/25 | 17/25 | 17/25 | 21/25 | 17/25 | 14/25 | 13/25 |
| Cost/Day | $0.41 | $0.30 | $0.21 | $0.16 | $0.20 | $0.27 | $0.24 | $0.25 | $0.13 | $0.10Winner |
| Dose/Serving | 20mg | 20mg | 20mg | 10mg | 20mg | 20mg | 10mg | 23mg | 10mg | 40mg |
| Form | Sugar cane wax policosanol, hypoallergenic vegetarian capsule | Sugar cane wax policosanol, vegetable capsule | Sugar cane wax policosanol, vegetarian capsule | Sugar cane wax policosanol, vegetarian capsule | Sugar cane policosanol, gelatin capsule | Sugar cane policosanol blend, tablet | Rice bran policosanol with MCT and lecithin, softgel | Sugar cane wax policosanol, mini-tablet | Sugar cane policosanol, capsule | Sugar cane policosanol, capsule |
| Third-Party Tested | ✓ Yes | No | No | No | No | No | No | No | No | No |
| Proprietary Blend | No | No | No | No | No | No | No | No | No | No |
Frequently Asked Questions
Why are the Cuban results so different from independent trials?
The Center of Natural Products in Havana published more than 80 positive trials between roughly 1991 and 2006, almost all using the same Cuban-manufactured policosanol product (Dalmer Laboratories). When investigators in Germany, South Africa, the US, and Canada ran blinded placebo-controlled trials with both Cuban-source and other-source material, none could reproduce the LDL effect. The most plausible explanations are methodological: possible unblinding, patient selection, lipid assay protocols, or analysis decisions in the original trials. The molecule, dose, and duration were the same. The result was not. This is one of the cleanest examples in supplement research of a finding that failed independent replication.
Is policosanol a viable statin alternative?
No. Berthold 2006 (JAMA) tested 10, 20, 40, and 80mg/day for 12 weeks against placebo and found no LDL reduction at any dose. Cubeddu 2006 directly compared 20mg policosanol to 10mg atorvastatin: atorvastatin cut LDL 35 percent, policosanol did nothing. If you cannot tolerate statins, the better-evidenced non-statin options are red yeast rice (which contains naturally occurring monacolin K, chemically related to lovastatin), bergamot extract (BPF standardized), berberine (500mg twice daily), and plant sterols (2-3g/day). All have stronger independent trial data than policosanol for LDL reduction.
Does the source matter? Cuban vs sugar cane vs beeswax vs rice bran?
The original positive trials used Cuban sugar cane wax policosanol from Dalmer Laboratories, which is not commercially sold in the US. Most US retail policosanol is also sugar cane-derived but from non-Cuban sources, with similar long-chain alcohol composition (mostly octacosanol, plus triacontanol and hexacosanol). Beeswax-derived and rice bran-derived versions have a different alcohol profile and even less evidence. Kassis & Jones 2006 specifically tested Cuban sugar cane policosanol in a Western lab setting and still found no effect, which weakens the source-specificity argument.
If it doesn't work for cholesterol, why is it still on shelves?
Three reasons. First, the original Cuban literature is large and impressive in volume and got picked up in the early 2000s by major US supplement brands and Life Extension, who built marketing around it. Second, the independent replication failures came in 2006 but never received the same publicity. Third, US supplement labeling is not required to update marketing claims based on contradicting evidence as long as it carries the standard FDA disclaimer. The product is safe and cheap to manufacture, so brands keep selling it.
What about the platelet aggregation effect?
This is the one area where independent signal exists. Cuban trials and at least one non-Cuban replication showed that 10-20mg/day reduces ADP-induced platelet aggregation in a dose-dependent way. The mechanism is reasonably plausible. However, no trials have shown this translates into reduced thrombotic events, stroke, or heart attack. Aspirin has 50+ years of hard outcome data for the same indication. If platelet inhibition is your goal, talk to your doctor about aspirin or prescribed antiplatelet therapy rather than relying on policosanol.
Can I stack policosanol with red yeast rice or a statin?
With red yeast rice or a statin, the cholesterol-related rationale to stack is weak because policosanol does not reliably move LDL on its own. Cubeddu 2006 specifically tested policosanol added to atorvastatin and found zero additional benefit beyond the statin alone. Stacking with anticoagulants or NSAIDs is more concerning because of the platelet aggregation effect, and that combination should be cleared with a physician. There is no strong rationale to add policosanol to any cholesterol-lowering regimen.
How long should I try it before deciding it's not working?
If you are running a personal trial, 8-12 weeks at 20mg/day is enough. The Cuban trials and the negative independent trials both used 8-12 week durations. Get a fasting lipid panel before starting and another at week 12. If LDL has not dropped at least 10 percent, the supplement is not working for you, which would put you in the same camp as essentially every patient in the independent replication trials. Stop and try a better-evidenced option.
Sources
- Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA. 2006;295(19):2262-9.
- Greyling A, De Witt C, Oosthuizen W, Jerling JC. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Br J Nutr. 2006;95(5):968-75.
- Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. Am Heart J. 2006;152(5):982.e1-5.
- Dulin MF, Hatcher LF, Sasser HC, Barringer TA. Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial. Am J Clin Nutr. 2006;84(6):1543-8.
- Kassis AN, Jones PJ. Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons. Am J Clin Nutr. 2006;84(5):1003-8.
- Mas R, Castano G, Illnait J, et al. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clin Pharmacol Ther. 1999;65(4):439-47. (Representative positive Cuban trial)
- Batista J, Stusser R, Saez F, Perez B. Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients. A 14-month pilot study. Int J Clin Pharmacol Ther. 1996;34(3):134-7. (Representative positive Cuban trial)
- Valdes S, Arruzazabala ML, Fernandez L, et al. Effect of policosanol on platelet aggregation in healthy volunteers. Int J Clin Pharmacol Res. 1996;16(2-3):67-72.
- Chen JT, Wesley R, Shamburek RD, Pucino F, Csako G. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy. 2005;25(2):171-83. (Pre-2006 meta-analysis dominated by Cuban trials; conclusions did not survive subsequent independent replications)
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products discussed on this page are not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any supplement regimen.